GlobeNewswire by notified

Sectigo’s Root Causes Cybersecurity Podcast Hits 150,000 Listeners

Share

Weekly Podcast Hosted by Industry Veterans Explores Digital Identity, Identity-first Security, Public Key Infrastructure, Quantum Computing, Blockchain, and Cryptographic Connections in Today’s Evolving Computing World

ROSELAND, N.J., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Sectigo®, a global leader in digital certificates and automated Certificate Lifecycle Management (CLM), today announced its five-star rated Root Causes weekly podcast reached its 150,000 listeners milestone and is among the top 10 percent of global podcasts in popularity, as ranked by Listen Score.

Hosted by Sectigo’s Chief Experience Officer, Tim Callan and Head of Product, Jason Soroko, the podcast features discussion and commentary around major trends impacting the cybersecurity industry. More than 250 episodes are available for digestible, easy-listening insights into a broad range of topics such as digital identities and identity-first security, public key infrastructure (PKI), CLM, quantum cryptography, blockchain, passwordless, zero trust, and much more.

“Thank you for providing ‘key’ information on PKI and digital identity topics. It is an awesome way to stay current and learn how to protect digital assets in a constantly changing landscape,” wrote one five-star reviewer.

Another wrote: “[I’ve] been in the systems engineering space for 10 years and I’ve continued to struggle with PKI and CA [Certificate Authorities]. This podcast has slowly filled those gaps in helping me understand soup to nuts what it’s all about, the risks, and what ‘right’ looks like.”

Popular episodes this year include:

  1. Tim’s Big Phishing Adventure
  2. CISA Recommendations for Post-Quantum Crypto
  3. Is China Outspending the West in Quantum Computing?
  4. One-time Passcode as a Liability
  5. What Is Lattice-based Cryptography?

“As we continue to see increasingly sophisticated cyber threats disrupting businesses, new digital privacy laws, regulations on cryptocurrencies, and continued hype around transformational technologies like the metaverse, Web3, and quantum computing, it’s crucial organizations of all sizes take a hard look at their cybersecurity strategies,” Callan said.

Soroko added: “Weak digital identity credentials continue to be used as an attack surface, and at a time when there is a proliferation of human and machine identities accessing sensitive corporate data, adopting an identity-first security posture must be a top priority. We are proud our podcast continues to be a valued voice in an ever-evolving industry to help CISOs and their teams establish digital trust to securely conduct business today.”

Root Causes streams on Spotify, SoundCloud, Blubrry, Stitcher, and iTunes, and it is also available at www.sectigo.com/resource-library/podcasts.

About Sectigo

Sectigo is a leading provider of digital certificates and automated Certificate Lifecycle Management (CLM) solutions - trusted by the world’s largest brands. Its cloud-based universal CLM platform issues and manages the lifecycles of digital certificates issued by Sectigo and other Certificate Authorities (CAs) to secure every human and machine identity across the enterprise. With over 20 years of experience establishing digital trust, Sectigo is one of the longest-standing and largest CAs with more than 700,000 customers, including 36% of the Fortune 1000. For more information, visit www.sectigo.com.

Sectigo Contact:
Elliot Harrison, Director of Global Communications
Sectigo
elliot.harrison@sectigo.com

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Monthly information regarding the total number of voting rights and total number of shares of the Company as of November 30, 20228.12.2022 22:30:00 CET | Press release

Monthly information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2022 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Market : NYSE Euronext Paris ISIN Code: FR 0010417345 Date Total number of sharesTotal number of voting rights11/30/2022 94,137,145 Total gross of voting rights: 94,137,145 Total net* of voting rights: 93,966,891 * Total net = total number of voting rights attached to shares – shares without voting rights Attachment PDF Version

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants8.12.2022 22:00:00 CET | Press release

Company announcement – No. 57 / 2022 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Copenhagen, Denmark and Boston, MA, U.S. December 8, 2022 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has increased its share capital by a nominal amount of DKK 64,919 divided into 64,919 new shares with a nominal value of DKK 1 each. The increase is a consequence of the exercise of warrants granted under several of Zealand Pharma's employee warrant programs. Employee warrant programs are part of Zealand Pharma’s incentive scheme, and each warrant gives the owner the right to subscribe for one new Zealand Pharma share at a prespecified price, the exercise price, in specific predefined time periods before expiration. For a more detailed description of Zealand Pharma’s warrant programs, see the company’s Articles o

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such8.12.2022 21:40:00 CET | Press release

COPENHAGEN, Denmark, December 8, 2022 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such. 1.Details of the person discharging managerial responsibilities/person closely associateda)NamePaul Chaplin2.Reason for the notificationa)Position/status President and Chief Executive Officer of Bavarian Nordic A/S b)Initial notification/AmendmentInitial notification3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora)NameBavarian Nordic A/Sb)LEI2138006JCDVYIN6INP514.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducteda)Description of the financial instrument, type of instrument Identification codeWarrants DK0015

Indberetning af ledende medarbejdere og disses nærtståendes transaktioner med Bavarian Nordic aktier og tilknyttede værdipapirer8.12.2022 21:40:00 CET | pressemeddelelse

KØBENHAVN, Danmark, 8. december 2022 – Bavarian Nordic A/S (OMX: BAVA) har dags dato modtaget oplysninger om følgende transaktioner med selskabets aktie/tilknyttede værdipapirer, foretaget af ledende medarbejdere og/eller personer/firmaer der er nærtstående til disse. 1.Nærmere oplysninger om personen med ledelsesansvar/personen med nær tilknytning til dennea)NavnPaul Chaplin2.Årsag til indberetningena)Stilling/titelAdministrerende direktør i Bavarian Nordic A/Sb)Første indberetning/ændringFørste indberetning3.Nærmere oplysninger om udstederen, deltageren på markedet for emissionskvoter, auktionsplatformen, auktionsholderen eller den auktionstilsynsførendea)NavnBavarian Nordic A/Sb)LEI-kode2138006JCDVYIN6INP514.Nærmere oplysninger om transaktionen/transaktionerne: gentages for i) hver type instrument, ii) hver type transaktion, iii) hver dato og iv) hvert sted, hvor der er udført transaktionera)Beskrivelse af det finansielle instrument, instrumenttypen IdentifikationskodeTegningsoption

Bavarian Nordic iværksætter nyt incitamentsprogram for koncernledelsen og udvalgte medarbejdere8.12.2022 21:35:00 CET | pressemeddelelse

KØBENHAVN, Danmark, 8. december 2022 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at bestyrelsen har besluttet at udstede tegningsoptioner til koncernledelsen og udvalgte medarbejdere i Bavarian Nordic koncernen. Som et nyt initiativ vil erhvervelsen (vesting) af tegningsoptioner for medlemmer af koncernledelsen være baseret på succesfuld opnåelse af relevante Key Performance Indicators (KPI’er). Beslutningen er truffet i henhold til generalforsamlingens bemyndigelser til bestyrelsen, jf. vedtægternes § 5b og 5c, og i overensstemmelse med selskabets vederlagspolitik. Der tildeles i alt 248.787 tegningsoptioner til medlemmer af koncernledelsen til en udnyttelseskurs på DKK 224,70 pr. aktie, svarende til markedskursen for Bavarian Nordics aktie på tildelingstidspunktet. Erhvervelse af tegningsoptionerne er betinget af forudgående opfyldelse af KPI’er, som fastsættes af bestyrelsen. Der tildeles i alt 683.264 tegningsoptioner til udvalgte medarbejdere i Bavarian Nordic koncernen til